Catalent, Inc. (CTLT) Social Stream



Catalent, Inc. (CTLT): $110.15

0.95 (+0.87%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Catalent Inc (CTLT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CTLT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-03 10 $172 $132 $156.6 $110.83 41.3%
2021-11-15 10 $172 $132 $156.8 $110.83 41.48%
2021-12-01 10 $172 $132 $157.5 $110.83 42.11%
2022-01-05 10 $172 $132 $157.727 $110.83 42.31%
2022-02-01 11 $172 $132 $157.727 $110.83 42.31%
2022-02-02 11 $168 $145 $159.9 $110.83 44.28%
2022-02-03 11 $167 $129 $150.6 $110.83 35.88%
2022-03-11 11 $160 $129 $149.3 $110.83 34.71%

The Trend in the Analyst Price Target


CTLT's average price target has moved up $57.5 over the prior 20 months.

CTLT reports an average of 37.1% for its upside potential over the past 128 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-03 10 172 132 156.6 136.01 15.14%
2021-12-01 9 172 132 157.5 127.31 23.71%
2021-12-01 10 172 132 157.5 127.31 23.71%
2022-02-02 11 167 140 154.1 106.19 45.12%
2022-02-02 11 168 145 159.9 106.19 50.58%

CTLT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.32 8 2 1 0 0 11

The Trend in the Broker Recommendations


CTLT's average broker recommendation rating improved by 0 over the prior 28 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CTLT as an investment opportunity.

  • Catalent Inc's average analyst price target is higher than 839.86% of all US stocks.
  • CTLT has a greater upside potential (average analyst target price relative to current price) than 180.41% of Pharmaceutical Products stocks.
  • Catalent Inc's variance in analysts' estimates is lower than -81.72% of Pharmaceutical Products stocks.
  • CTLT has a higher number of analysts covering the stock than 817.53% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, BMY, BMRN, and BHC are the three stocks most similar to Catalent Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding CTLT using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4423 seconds.